Share of Clicks for top 10 US Pharma & Biotech Infectious Diseases brands
Here are the Top 10 competitors in the industry by Share of Clicks for the last month.
| Domain | Share of clicks |
|---|---|
| paxlovid.com | 20.53 |
| uqora.com | 13.81 |
| mavyret.com | 13.19 |
| admired.com | 5.27 |
| symtuzahcp.com | 3.4 |
| mayoclinic.org | 3.3 |
| epclusa.com | 2.99 |
| talk-prep.com | 2.83 |
| skyrizi.com | 2.42 |
| dndi.org | 2.3 |
| others | 29.96 |
- paxlovid.com - 20.53%
- uqora.com - 13.81%
- mavyret.com - 13.19%
- admired.com - 5.27%
- symtuzahcp.com - 3.4%
- mayoclinic.org - 3.3%
- epclusa.com - 2.99%
- talk-prep.com - 2.83%
- skyrizi.com - 2.42%
- dndi.org - 2.3%
- others - 29.96%
Copyright © Adthena. All rights reserved.
In the PPC landscape, paxlovid.com leads with 20.53% click share, followed by uqora.com at 13.81%. Mavyret.com holds 13.19%, while ‘others’ collectively capture 29.96%.
Share of Spend for the top 10 US Pharma & Biotech Infectious Diseases brands
Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month.
| Date | mavyret.com | paxlovid.com | uqora.com | talk-prep.com | cabenuva.com | skyrizi.com | epclusa.com | admired.com | symtuzahcp.com | mayoclinic.org |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/02/01 | 27.3% | 1.27% | 4.16% | 5.47% | 6.93% | 2.89% | 6.23% | 1.9% | 7.85% | 2.29% |
| 2026/02/02 | 13.47% | 6.76% | 3.7% | 4.72% | 3.79% | 6.67% | 2.97% | 1.89% | 7.23% | 2.12% |
| 2026/02/03 | 15.75% | 9.7% | 9.58% | 3.81% | 4.56% | 6.38% | 5.14% | 2.33% | 4.31% | 0.08% |
| 2026/02/04 | 17.68% | 6.89% | 9.17% | 3.59% | 6.71% | 3.88% | 4.66% | 2.87% | 5.11% | 4.47% |
| 2026/02/05 | 11.4% | 10.53% | 11.46% | 2.89% | 5.73% | 1.22% | 3.05% | 3.82% | 4.44% | 6.11% |
| 2026/02/06 | 15.65% | 9% | 6.85% | 4.36% | 3.69% | 1.37% | 8.05% | 4.71% | 5.53% | 5.59% |
| 2026/02/07 | 14.82% | 6.31% | 6.05% | 6.2% | 5.42% | 2.87% | 6.42% | 4.43% | 2.72% | 1.9% |
| 2026/02/08 | 10.2% | 8.08% | 6.39% | 4.76% | 9% | 0.68% | 2.82% | 3.14% | 4.71% | 2.09% |
| 2026/02/09 | 12.91% | 7.59% | 13.24% | 4.53% | 4.15% | 3.69% | 2.48% | 4.18% | 4.85% | 3.06% |
| 2026/02/10 | 14.27% | 9.91% | 8.78% | 4.54% | 3.45% | 2.37% | 7.42% | 2.86% | 4.44% | 0.58% |
| 2026/02/11 | 17.61% | 7.59% | 8.23% | 3.26% | 2.41% | 3.94% | 5.49% | 2.69% | 3.8% | 11.63% |
| 2026/02/12 | 11.4% | 10.53% | 11.46% | 2.89% | 5.73% | 1.22% | 3.05% | 3.82% | 4.44% | 6.11% |
| 2026/02/13 | 15.43% | 8.87% | 6.76% | 4.3% | 3.64% | 1.35% | 7.94% | 4.64% | 5.45% | 5.51% |
| 2026/02/14 | 14.76% | 6.29% | 6.03% | 6.17% | 5.4% | 2.86% | 6.39% | 4.42% | 2.71% | 1.9% |
| 2026/02/15 | 10.19% | 8.07% | 6.39% | 4.76% | 9% | 0.68% | 2.82% | 3.14% | 4.71% | 2.09% |
| 2026/02/16 | 12.9% | 7.59% | 13.24% | 4.53% | 4.15% | 3.69% | 2.48% | 4.18% | 4.85% | 3.06% |
| 2026/02/17 | 8.2% | 8.48% | 0% | 1.89% | 5.46% | 0.44% | 9.11% | 1.25% | 4.72% | 1.17% |
| 2026/02/18 | 22.57% | 2.2% | 6.44% | 5.28% | 2.65% | 4.17% | 4.59% | 2.47% | 2.6% | 3.47% |
| 2026/02/19 | 17.36% | 1.64% | 6.51% | 3.86% | 3.62% | 4.64% | 4.49% | 1% | 5.09% | 9.14% |
| 2026/02/20 | 21.46% | 10.84% | 14.7% | 5.63% | 3.58% | 2.89% | 5.13% | 3.74% | 2.97% | 0.23% |
| 2026/02/21 | 24.17% | 18.57% | 2.84% | 6.93% | 2.15% | 6.95% | 2.64% | 1.6% | 2.79% | 0.1% |
| 2026/02/22 | 24.99% | 10.38% | 8.37% | 5.91% | 0.63% | 0.61% | 4% | 1.74% | 1.69% | 3.71% |
| 2026/02/23 | 18.9% | 8.8% | 0% | 4.41% | 0.71% | 4.81% | 3.57% | 1.32% | 1.63% | 4.5% |
| 2026/02/24 | 27.51% | 1.66% | 4.67% | 6.4% | 0.76% | 4.92% | 2.23% | 3.04% | 2.62% | 0.68% |
| 2026/02/25 | 24.4% | 0.48% | 13.17% | 3.42% | 0.39% | 8.01% | 1.94% | 1.31% | 1.2% | 8.54% |
| 2026/02/26 | 22.14% | 6.31% | 4.37% | 4.74% | 0.45% | 7.08% | 2.63% | 1.67% | 1.63% | 7.43% |
| 2026/02/27 | 13.86% | 15.86% | 10.45% | 9.07% | 2% | 5.69% | 1.82% | 2.99% | 0.93% | 3.22% |
| 2026/02/28 | 24.59% | 9.3% | 9.07% | 8.17% | 3.97% | 3.13% | 2.89% | 2.78% | 1.08% | 0.05% |
- mavyret.com
- paxlovid.com
- uqora.com
- talk-prep.com
- cabenuva.com
- skyrizi.com
- epclusa.com
- admired.com
- symtuzahcp.com
- mayoclinic.org
Copyright © Adthena. All rights reserved.
Mavyret.com dominated February, peaking at 27.51% on the 24th. Paxlovid.com surged mid-month, reaching 18.57% on the 21st. Uqora.com maintained steady growth, while Talk-prep.com and Cabenuva.com fluctuated. The month concluded with Mavyret.com leading.
Competitor Count for US Pharma & Biotech Infectious Diseases
Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month.
| Date | Competitor Count |
|---|---|
| 2026/02/01 | 78 |
| 2026/02/02 | 82 |
| 2026/02/03 | 72 |
| 2026/02/04 | 75 |
| 2026/02/05 | 76 |
| 2026/02/06 | 81 |
| 2026/02/07 | 78 |
| 2026/02/08 | 81 |
| 2026/02/09 | 80 |
| 2026/02/10 | 82 |
| 2026/02/11 | 79 |
| 2026/02/12 | 76 |
| 2026/02/13 | 81 |
| 2026/02/14 | 78 |
| 2026/02/15 | 81 |
| 2026/02/16 | 80 |
| 2026/02/17 | 79 |
| 2026/02/18 | 84 |
| 2026/02/19 | 84 |
| 2026/02/20 | 79 |
| 2026/02/21 | 74 |
| 2026/02/22 | 78 |
| 2026/02/23 | 76 |
| 2026/02/24 | 80 |
| 2026/02/25 | 72 |
| 2026/02/26 | 71 |
| 2026/02/27 | 72 |
| 2026/02/28 | 72 |
Copyright © Adthena. All rights reserved.
In February, advertiser numbers fluctuated, peaking at 84 on the 18th and 19th. The month concluded with a steady 72, reflecting a dynamic yet stable landscape.
